Center proposes strengthening quality control of medicines at all stages from production to pharmacies
Read more
The times of India
timesofindia.indiatimes.com

Center proposes strengthening quality control of medicines at all stages from production to pharmacies

It is proposed that medicinal products could undergo stricter checks not only at manufacturing facilities but also throughout their journey to pharmacies and patients. The Center intends to incorporate Good Storage and Distribution Practices (GSDP) into the 1945 Drug Regulations.

Furthermore, a higher level of requirements for documentation, traceability, and accountability will be established for all participants in the pharmaceutical supply chain, including manufacturers, importers, wholesalers, distributors, warehouse workers, and other related entities.

Similar stories

Center introduces stricter control over antibiotic production and raw material trade
Read more
timesofindia.indiatimes.com

Center introduces stricter control over antibiotic production and raw material trade

To strengthen supervision over the pharmaceutical supply chain and combat antimicrobial resistance (AMR), the Center has proposed introducing stricter regulations for both the production and wholesale distribution of antibiotics and other raw medicinal substances.

According to the proposed changes, obtaining new permits for the production of antimicrobial drugs will require prior approval from the Center. Furthermore, wholesale traders dealing with raw materials, including active pharmaceutical ingredients (APIs), will need to obtain a separate license to improve control over the movement of these substances.

The proposed centralized control aims to ensure the quality and efficacy of medications, as low-quality or ineffective antimicrobial drugs can contribute to the development of drug resistance and complicate infection treatment.

Popular